Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
5.80's EOY I would be very disappointed. EOD yes, that would be nice.
Some people conveniently like to leave that out. So much for facts- and truth finding.
Now looks like a good time to add. Nice discount.
Millions of people take Aricept yet there are just very few of these anecdotal cases of positive responders?
Anavex has 6 strong responders in a tiny trial with a far superior safety profile compared to Aricept.
Judge for yourself after reading this:
http://www.askapatient.com/viewrating.asp?drug=20690&name=ARICEPT
NASDAQ is down 2% because of Apple. Not much to do with AVXL.
Hey as long as you are long AVXL there is some hope I guess..
Keep singing those ol' tunes of yours Kenneth.
Here's a good example of hyper-placebo-osis:
https://www.facebook.com/TheProjectTV/videos/10154154448498441/?hc_ref=SEARCH
Our friend Amit from Sneaking Alpha is still short AVXL...
https://seekingalpha.com/article/4078201-pro-weekly-digest-investing-using-sentiment-analysis-amit-ghate
Unfortunately for him AVXL is going in the wrong direction.
I wonder when the Baker Brothers are going to take a sizeable stake in Anavex. They should be aware of our little company by now.
The most successful biotech stories were those companies with the least fluff PR's. Let the man do his job. Missling is doing just fine.
Some Seeking Alpha contributors, who are far less informed on the subject matter than you, feel entitled to spout false claims about Anavex's science and business. Would love to see your write-ups on Seeking Alpha so investors can have a clear grasp of what Anavex is all about.
Then sell and buy back in 2018. See if you can get shares for under $6 then.
I was wondering. If Sigma-1 will be the new revolution in medicine, will antisense drugs and therapies become redundant?
Multiple low volume days right at the 50SMA makes for a good entry point for those who are interested to buy shares.
For the impatient folks I think it's best to stop watching the ticker every day. It may lead to decisions you will come to regret later on. Go outside, enjoy life. All will be good.
Yes, thanks Kund :) And thanks Talon for making these points clear to new investors and the misguided shorts.
Amit WHO?
These rituals pay off, look at after hours trading :)
Last year's presentation on Epilepsy was a good one:
https://www.epilepsy.com/atom/18601
I hope we get substantially more information this time around.
I was greedy and added more when the stock was in the 3's. Feels good to be greedy sometimes, that I can tell you.
Latest 13F's just out;
https://fintel.io/so/us/avxl
Good article. Paul Aisen...is'nt he on the Anavex Advisory Board?
Ummm it's a financial report for the 2nd quarter...And if you paid attention to the board you would know that Rett's will start somewhere in the fall of this year. Btw, Missling does not get paid 11 million a year and you know that.
Sure looks like a quiet period. Here's an interesting article on quiet periods:
http://westwickepartners.com/2014/06/commonly-asked-questions-about-quiet-periods/
Bipartisan Congressional Task Force on Alzheimer's Disease
http://www.ciclt.net/sn/pol/poc_detail.aspx?P_ID=&ClientCode=masc&LegComID=19968
A nice list of people with contact information. Do with it what you want.
Found this site with indepth information on A2-73, maybe you guys can find some interesting stuff in here.
https://pubchem.ncbi.nlm.nih.gov/compound/46932299#section=Top
The epilepsy patent information is good news for many of us and shows again how wrong Adam Feuerstein has been on Anavex all along. I suggest that you start studying the science a little bit more and fixate less on AF's libelous write-ups and tweets.
Judging by the side effects, Bryostatin can be used as a laxative against constipation perhaps?
Smart money moving out again?
I bet some Rockefeller made out like a bandit on this one.
Some people don't seem to realise that they hold a lottery ticket with high winning odds in their hands and are considering giving it to someone else for lack of confidence or impatience. Imagine selling shares now and see the share price explode soon thereafter. Talk about syndromes, ouch! I would't want to be in that camp.
Instead of buying 100 AVXL shares, why not invest in Rockefeller funds? If you can't beat them, join them. You'll make a killing i'm sure!
Anyone who sincerely tries to beat Alzheimer's is a good doctor in my book.
Apparantly many investors in Europe didn't have the ability to vote because of brokers unwilling to co-operate.
From Kingsdale;
Dear Mr xxx,
I unfortunately did not receive any alternatives and it appears that for the time-being, the European institutions will have to reach out to their North American custodians to obtain the voting control numbers. If there are any updates that could simplify the process going forward, we will let you know.
Once again my sincerest apologies that I was not able to take care of this matter for you in a more satisfactory way.
Please do not hesitate to contact me again.
Best Regards,
Jeremy Salvador
Call Centre Agent
Kingsdale Advisors
With such low confidence in our researchers I take it that you are not long AVXL anymore then.
You need a 16 digit control number, with that you can vote online.
I thought it was up only on news of a new CEO.
Noble Financial Reiterates Buy Rating for Anavex Life Sciences Corp. (AVXL)
https://www.thecerbatgem.com/2017/04/09/noble-financial-reiterates-buy-rating-for-anavex-life-sciences-corp-avxl.html
A little more on Harald Hampel
Harald Hampel has, during the past years, received lecture honoraria and/or research grants and/or travel funding and/or participated in scientific advisory boards and/or served as a consultant to diagnostic, biotechnology and pharmaceutical companies involved in the manufacture and marketing of biomarkers and/or diagnostics and/or drugs or medicinal products for cognitive impairment and/or Alzheimer's disease. These companies include Boehringer-Ingelheim, Bristol-Myers Squibb, Elan Corporation, Wyeth, Novartis, Eisai, Pfizer, Schwabe, Sanofi-Aventis, Roche Pharmaceuticals and Diagnostics, GE Healthcare, Astra-Zeneca, Avid, Eli Lilly and Company, Janssen-Cilag, Merz Pharmaceuticals, GlaxoSmithKline-Biologicals, Jung-Diagnostics and Thermo Fisher Scientific Clinical Diagnostics. He is co-inventor in pending patent submissions relating to biological markers and/or diagnostics.
Is that enough expertise for you Amatuer?